1)- Sophie Marbaix, Annick Mignon, Audrey Taelman, Ahuva Averin, Mark Atwood, Jeffrey Vietri. Cost-utility of 20-valent pneumococcal conjugate vaccine compared to no vaccination and recommended alternative vaccines among Belgian adults.Expert review of vaccines. 2023, 22 (1): 1008-1021
3)- Timo Vesikari, Joanne M Langley, Vlad Popovic, Francisco Diaz-Mitoma. PreHevbrio: the first approved 3-antigen hepatitis B vaccine.Expert review of vaccines. 2023, 22 (1): 1041-1054
4)- Charlotte Sorieul, Marta Dolce, Maria Rosaria Romano, Jeroen Codée, Roberto Adamo. Glycoconjugate vaccines against antimicrobial resistant pathogens.Expert review of vaccines. 2023, 22 (1): 1055-1078
5)- Yingping Chen, Xinpei Zhang, Lihui Gong, Zhenzhen Liang, Xiaosong Hu, Bo Xing, Yuting Liao, Lingfeng Yuan, Gang Chen, Huakun Lv. Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older.Expert review of vaccines. 2023, 22 (1): 1079-1090
6)- Maria L Avila Agüero, Jose Brea Del Castillo, Luiza Helena Falleiros-Arlant, Eitan Berezín, Jose Cassio de Moraes, Carlos Torres-Martínez, Eduardo L Lopez, María E Castillo, Almudena Laris-Gonzalez, Fortino Solorzano, Angela Gentile, Juan Pablo Torres Torretti, Eduardo López-Medina. Risks of low vaccination coverage and strategies to prevent the resurgence of vaccine-preventable diseases in infants in the COVID-19 pandemic scenario: recommendations for Latin America and the Caribbean by the group of experts on infant immunization for Latin America.Expert review of vaccines. 2023, 22 (1): 1091-1101
8)- Claire E Mellott, Rafal Jaworski, Justin Carrico, Sandra E Talbird, Iwona Dobrowolska, Dominik Golicki, Goran Bencina, Micah Clinkscales, Eugenia Karamousouli, Amanda L Eiden, Ugne Sabale. Public health impact and return on investment of the pediatric immunization program in Poland.Expert review of vaccines. 2023, 22 (1): 1114-1125
9)- María L Avila-Agüero, Sebastián Ospina-Henao, Cristina Mariño, Mirella Vázquez-Rivera, Juan Pablo Torres, Dora Estripeaut, Rolando Ulloa-Gutierrez, Angela Gentile. Vaccination against pertussis in Latin American preterm and low-birth weight infants: experts opinion position for a neglected childhood age group.Expert review of vaccines. 2023, 22 (1): 1126-1135
10)- Jéssica L Chechi, Felipe A C da Costa, Julia M Figueiredo, Cássia M de Souza, Alessandro F Valdez, Daniel Zamith-Miranda, Aline C Camara, Carlos P Taborda, Joshua D Nosanchuk. Vaccine development for pathogenic fungi: current status and future directions.Expert review of vaccines. 2023, 22 (1): 1136-1153
13)- Marco Del Riccio, Sara Boccalini, Claudia Cosma, Gabriele Vaccaro, Benedetta Bonito, Beatrice Zanella, Cristina Salvati, Duccio Giorgetti, Lisa Rigon, Massimiliano Alberto Biamonte, Matteo Monami, Paolo Bonanni, Angela Bechini. Effectiveness of pneumococcal vaccination on hospitalization and death in the adult and older adult diabetic population: a systematic review.Expert review of vaccines. 2023, 22 (1): 1179-1184
14)- Hui Han, Dan Zhao, Xinru Fang, Wenming Yang, Mengli Wang, Qianzhuo Liu, Luyao Wang, Zhihui Ji, Juan Zhang, Zhifeng Hou, Lei Hua, Yu Wang, Limin Wu. A retrospective cohort study: vaccination status and safety analysis of SARS-CoV-2 vaccine in patients with Wilson's disease.Expert review of vaccines. 2023, 22 (1): 1185-1195
16)- Giacomo Casabona, Olivia Berton, Tina Singh, Markus Knuf, Paolo Bonanni. Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context.Expert review of vaccines. 2023, 22 (1): 764-776
17)- Angel Shabu, Prasad S Nishtala. Analysis of the adverse events following the mRNA-1273 COVID-19 vaccine.Expert review of vaccines. 2023, 22 (1): 801-812
19)- Ahmed Tawfik, Takahisa Kawaguchi, Meiko Takahashi, Kazuya Setoh, Izumi Yamaguchi, Yasuharu Tabara, Kristel Van Steen, Anavaj Sakuntabhai, Fumihiko Matsuda. Trivalent inactivated influenza vaccine response and immunogenicity assessment after one week and three months in repeatedly vaccinated adults.Expert review of vaccines. 2023, 22 (1): 826-838
20)- Cynthia Burman, Jamie Findlow, Helen S Marshall, Marco A P Safadi. National and regional differences in meningococcal vaccine recommendations for individuals at an increased risk of meningococcal disease.Expert review of vaccines. 2023, 22 (1): 839-848
22)- Karan Thakkar, Julia Spinardi, Moe H Kyaw, Jingyan Yang, Carlos Fernando Mendoza, Egemen Ozbilgili, Josie Dodd, Ben Yarnoff, Suda Punrin. Modelling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Thailand.Expert review of vaccines. 2023, 22 (1): 860-870
24)- Eleana Tsoumani, John A Carter, Stina Salomonsson, Jennifer M Stephens, Goran Bencina. Clinical, economic, and humanistic burden of community acquired pneumonia in Europe: a systematic literature review.Expert review of vaccines. 2023, 22 (1): 876-884
25)- Catherine J Y Tsai, Jacelyn M S Loh, Kohtaro Fujihashi, Hiroshi Kiyono. Mucosal vaccination: onward and upward.Expert review of vaccines. 2023, 22 (1): 885-899
26)- Ting Du, Qiuxia Qu, Yawen Zhang, Qin Huang. No observable influence of COVID-19 inactivated vaccines on pregnancy and birth outcomes in the first trimester of gestation.Expert review of vaccines. 2023, 22 (1): 900-905
27)- Shahrul Mt-Isa, Justin R Chumbley, Emma L Crawford, Natalie Banniettis, Ulrike K Buchwald, Jessica Weaver, Thomas Weiss. An indirect treatment comparison (ITC) and matching-adjusted indirect comparison (MAIC) between a 15-valent (V114) and a 20-valent (PCV20) pneumococcal conjugate vaccine among healthy infants.Expert review of vaccines. 2023, 22 (1): 906-917
28)- Peter D Skidmore, Rocio Canals, Maheshi N Ramasamy. The iNTS-GMMA vaccine: a promising step in non-typhoidal Salmonella vaccine development.Expert review of vaccines. 2023, 22 (1): 918-920
29)- Felicitas Kühne, Katharina Achtert, Franziska Püschner, Dominika Urbanski-Rini, Juliane Schiller, Ernestine Mahar, Josephine Friedrich, Mark Atwood, Ralf Sprenger, Jeffrey Vietri, Christof von Eiff, Christian Theilacker. Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany.Expert review of vaccines. 2023, 22 (1): 921-932
30)- Irnela Bajrovic, Maria A Croyle. Challenges in vaccine transport: can we deliver without the cold chain?Expert review of vaccines. 2023, 22 (1): 933-936
31)- Jovin J Y Choo, Christopher L D McMillan, Paul R Young, David A Muller. Microarray patches: scratching the surface of vaccine delivery.Expert review of vaccines. 2023, 22 (1): 937-955
33)- Richard Thomson-Luque, Thomas C Stabler, Kristin Fürle, Joana C Silva, Claudia Daubenberger. merozoite surface protein 1 as asexual blood stage malaria vaccine candidate.Expert review of vaccines. 2023, :